Mrv0541 02231216212D 9 8 0 0 0 0 999 V2000 1.0461 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7605 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4750 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1895 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9039 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6184 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0474 1.8414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 0.6039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 M END > DB02641 > drugbank > CCCCCCC(N)=O > InChI=1S/C7H15NO/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H2,8,9) > AEDIXYWIVPYNBI-UHFFFAOYSA-N > C7H15NO > 129.2001 > 129.115364107 > 1 > 24 > 4.077722364236362e-09 > 15.702685221045162 > 1 > 1 > 0 > 0 > heptanamide > 1.81 > 1.4485221790000002 > -1.53 > 0 > 0 > 0 > 0 > 17.11822683750171 > -1.3815449572120544 > 43.09 > 37.4968 > 5 > 1 > 3.79e+00 g/l > tetrahydrofolic acid > 0 > DB02641 > EXPT01772 > experimental > Heptanamide $$$$